Opportunity Information: Apply for CDC RFA GH12 1251

  • The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Supporting the National Blood Safety Program (NBSP) in the Implementation and Expansion of Blood Safety Activities in the Republic of Haiti under the Presidents Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067 Global AIDS.
  • This funding opportunity was created on Apr 7, 2012 and posted on Jan 20, 2012.
  • Applicants must submit their applications by Apr 21, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • The funding agency has allocated a total of $14,500,000.00 to eligible and selected applicants.
  • Each selected applicant is eligible to receive up to $2,500,000.00 in funding.
  • The number of recipients for this funding is limited to 1 candidate(s).
  • Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
  • This funding announcement is not a request for applications. This is a public notice of the Centers for Disease Control and Prevention s intention to fund the following project activities without full and open competition.
Apply for CDC RFA GH12 1251

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

This grant opportunity, titled "Supporting the National Blood Safety Program (NBSP) in the Implementation and Expansion of Blood Safety Activities in the Republic of Haiti under the President's Emergency Plan for AIDS Relief (PEPFAR)," is a U.S. Centers for Disease Control and Prevention (CDC) cooperative agreement intended to strengthen Haiti's national system for blood safety. The central aim is to continue supporting Haiti's National Blood Safety Program so the country can maintain and expand access to a safe and sufficient supply of blood and blood products. In practical terms, the opportunity is positioned around protecting patients and communities from transfusion-transmitted infections and ensuring that blood collection, testing, processing, and distribution function reliably enough to meet clinical needs across the country.

The funding mechanism is a cooperative agreement, which typically means CDC would be more actively involved than in a standard grant, providing substantial programmatic guidance, oversight, and collaboration during implementation. The program falls under the health category and is tied to PEPFAR, reflecting its relevance to HIV prevention and broader infectious disease safety in the blood supply. The associated CFDA number is 93.067 (Global AIDS), signaling that this work is part of the larger U.S. global HIV/AIDS response and aligns with efforts to reduce HIV transmission risks, including those associated with medical procedures like transfusion.

Financially, the notice lists an estimated total funding level of $14,500,000, with an award ceiling of $2,500,000 and no stated award floor. The anticipated number of awards is one, which is consistent with a single implementing partner supporting a national-level program. There is no cost-sharing or matching requirement, meaning the recipient would not be required to contribute non-federal funds as a condition of the award. The key dates show the opportunity was posted on January 20, 2012, created on April 7, 2012, with an original closing date of March 21, 2012 that was later extended to April 21, 2012, and an archive date of May 21, 2012. These dates indicate the notice is historical and no longer open.

A major feature of this announcement is that it is not a request for applications and was not intended to be competed through full and open competition. Instead, it serves as a public notice of CDC's intent to fund specified project activities through a noncompetitive process. The "Eligible Applicants" field is broad and references "Others," but the eligibility is effectively constrained by the noncompetitive nature of the award and the clarifying language indicating this is a notice of intent rather than a standard competitive funding opportunity. In other words, even though eligibility categories may be listed, the practical purpose is transparency about an intended award rather than inviting new applicants to submit proposals.

From a program standpoint, the opportunity is focused on implementing and expanding blood safety activities through the National Blood Safety Program infrastructure. While the short description does not list detailed tasks, the stated objective implies support for the core components required to ensure blood safety: building and maintaining systems that support voluntary blood donation, ensuring appropriate donor recruitment and screening, strengthening laboratory testing and quality systems, improving handling and storage procedures, and supporting distribution practices that preserve product safety and availability. Because it is framed as continuation support, it also suggests an emphasis on sustaining previously established systems and scaling them to meet broader national demand, likely including capacity building, standard operating procedures, monitoring and evaluation, and coordination among facilities and stakeholders involved in the blood supply chain.

The sponsor agency is the CDC, and the notice provides a point of contact for technical issues accessing the full announcement: the CDC Procurement and Grants Office Technical Information Management Section (TIMS) at 770-488-2700. The additional information link shown in the text is described as not active, with instructions to use the "Full Announcement" at the top of the original posting, reinforcing that the authoritative details were contained in the full announcement document rather than the summary fields alone.

Overall, this opportunity represents a targeted CDC/PEPFAR investment to reinforce Haiti's national capacity to provide safe, adequate blood and blood products, using a cooperative agreement structure and a single-award, noncompetitive approach to continue or expand an existing blood safety effort under the National Blood Safety Program.

Frequently Asked Questions (FAQs)

1. What is the title of this grant opportunity?

The opportunity is titled "Supporting the National Blood Safety Program (NBSP) in the Implementation and Expansion of Blood Safety Activities in the Republic of Haiti under the President's Emergency Plan for AIDS Relief (PEPFAR)."

2. Which U.S. agency is sponsoring this opportunity?

The sponsor agency is the U.S. Centers for Disease Control and Prevention (CDC).

3. What type of funding mechanism is being used?

This opportunity uses a cooperative agreement funding mechanism.

4. What does a "cooperative agreement" mean in this context?

Based on the notice, a cooperative agreement typically means CDC would be more actively involved than in a standard grant, providing substantial programmatic guidance, oversight, and collaboration during implementation.

5. What is the overall purpose of this cooperative agreement?

The central aim is to strengthen Haiti's national system for blood safety by continuing to support Haiti's National Blood Safety Program (NBSP) so Haiti can maintain and expand access to a safe and sufficient supply of blood and blood products.

6. What public health problem is the program trying to address?

The program is positioned around protecting patients and communities from transfusion-transmitted infections and ensuring that blood collection, testing, processing, and distribution function reliably enough to meet clinical needs across Haiti.

7. How is this opportunity connected to PEPFAR and HIV prevention?

The opportunity is tied to the President's Emergency Plan for AIDS Relief (PEPFAR) and is described as relevant to HIV prevention and broader infectious disease safety in the blood supply, including reducing HIV transmission risks associated with transfusions.

8. What is the CFDA number associated with this opportunity?

The CFDA number listed is 93.067 (Global AIDS).

9. What is the estimated total funding amount for this notice?

The notice lists an estimated total funding level of $14,500,000.

10. What is the award ceiling?

The award ceiling is $2,500,000.

11. Is there an award floor (minimum award amount)?

No award floor is stated in the notice.

12. How many awards were anticipated?

The anticipated number of awards is one.

13. Is cost sharing or matching required?

No. The notice states there is no cost-sharing or matching requirement.

14. Is this a competitive funding opportunity?

No. The announcement states it is not a request for applications and was not intended to be competed through full and open competition. It is presented as a public notice of CDC's intent to fund specified project activities through a noncompetitive process.

15. If it is noncompetitive, what does that imply for applicants?

Even though the "Eligible Applicants" field is described as broad and references "Others," the notice explains that eligibility is effectively constrained by the noncompetitive nature of the award and the fact that it is a notice of intent rather than an invitation for new applicants to submit proposals.

16. What types of activities does the opportunity support?

The short description does not list detailed tasks, but the stated objective implies support for the core components required to ensure blood safety. This includes building and maintaining systems that support voluntary blood donation, donor recruitment and screening, strengthening laboratory testing and quality systems, improving handling and storage procedures, and supporting distribution practices that preserve safety and availability.

17. Does the notice indicate this is continuation support or a new initiative?

It is framed as continuation support to sustain previously established systems and scale them to meet broader national demand.

18. What country and national program are the focus of the work?

The work is focused on the Republic of Haiti and specifically supports Haiti's National Blood Safety Program (NBSP).

19. What is the health category or program area for this opportunity?

The opportunity falls under the health category and is associated with PEPFAR and the broader Global AIDS (CFDA 93.067) program context.

20. Is this opportunity currently open?

No. The key dates indicate this notice is historical and no longer open (including an archive date of May 21, 2012).

21. What were the key dates listed in the notice?

The opportunity was posted on January 20, 2012, created on April 7, 2012, had an original closing date of March 21, 2012 that was extended to April 21, 2012, and an archive date of May 21, 2012.

22. Where were the authoritative details expected to be found?

The notice indicates that authoritative details were contained in the "Full Announcement" at the top of the original posting. It also notes the additional information link shown in the text is not active.

23. Who is the point of contact for technical issues accessing the full announcement?

The point of contact listed for technical issues is the CDC Procurement and Grants Office Technical Information Management Section (TIMS) at 770-488-2700.

24. What is the main operational goal for Haiti's blood system described in the notice?

The notice emphasizes maintaining and expanding access to a safe and sufficient supply of blood and blood products, with reliable nationwide functions for collection, testing, processing, and distribution to meet clinical needs.

25. Why would CDC issue this type of notice if it is not a request for applications?

Based on the description provided, the purpose is transparency: it serves as a public notice of CDC's intent to fund specified project activities through a noncompetitive process rather than inviting competitive applications.

Browse more opportunities from the same agency: Centers for Disease Control and Prevention

Browse more opportunities from the same category: Health

Next opportunity: Theodore Roosevelt Inaugural Site Operations and Management

Previous opportunity: Center of Excellence for Comprehensive Integrated HIV Care and Treatment Services in Lilongwe, Malawi

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for CDC RFA GH12 1251

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (CDC RFA GH12 1251) also looked into and applied for these:

Funding Opportunity
Targeting Inflammation and Immune Activation in HIV Disease (U01) Apply for RFA AI 12 007

Funding Number: RFA AI 12 007
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Building the Science of Public Reporting (R21) Apply for RFA HS 12 004

Funding Number: RFA HS 12 004
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: Case Dependent
National Quality Improvement/Management Technical Assistance Center (NQC) Cooperative Agreement Apply for HRSA 12 072

Funding Number: HRSA 12 072
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: $2,500,000
NIH Health Care Systems Research Collaboratory Coordinating Center (U54) Apply for RFA RM 11 021

Funding Number: RFA RM 11 021
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIH Health Care Systems Research Collaboratory Pragmatic Clinical Trials Demonstration Projects (UH2/UH3) Apply for RFA RM 12 002

Funding Number: RFA RM 12 002
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Provision of Comprehensive Public Health Services for the Fishing Communities in the Republic of Uganda under the Presidents Emergency Plan for AIDS Relief Apply for CDC RFA GH12 1211

Funding Number: CDC RFA GH12 1211
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $1,500,000
Increasing the Capacity of the Government of Suriname to Expand Coordinated HIV Prevention, Strategic Information, and Laboratory Programs in Suriname under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH12 1207

Funding Number: CDC RFA GH12 1207
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $250,000
Enhancement of Public, Private and Faith Based Health Laboratory Capacity to Support HIV/AIDS Prevention, Care and Treatment in the United Republic of Tanzania under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH12 1237

Funding Number: CDC RFA GH12 1237
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $300,000
District Health System Strengthening and Quality Improvement for Service Delivery in Malawi under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH12 1248

Funding Number: CDC RFA GH12 1248
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $6,000,000
National Maternal and Child Health Data Resource Center Cooperative Agreement Program Apply for HRSA 12 144

Funding Number: HRSA 12 144
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
Cancer Prevention and Control Programs for State, Territorial and Tribal Organizations Apply for CDC RFA DP12 1205

Funding Number: CDC RFA DP12 1205
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $9,000,000
Drug Free Communities Support Program Apply for SP 12 001

Funding Number: SP 12 001
Agency: Substance Abuse Mental Health Services Adminis.
Category: Health
Funding Amount: $125,000
Building the Institutional Capacity of Local Indigenous Organizations Implementing Comprehensive Clinical and Laboratory Services to Sustain and Enhance the Prevention, Care and Treatment of HIV/AIDS in the Federal Republic of Nigeria under PEPFAR Apply for CDC RFA GH12 1230

Funding Number: CDC RFA GH12 1230
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $500,000
Implementing Evidence Based Prevention Interventions to Prevent New HIV Infections in the United Republic of Tanzania Under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH12 1236

Funding Number: CDC RFA GH12 1236
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $540,000
Interventions to Improve HIV/AIDS and Alcohol Related Outcomes (U01) Apply for RFA AA 12 009

Funding Number: RFA AA 12 009
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Competing Revisions for Macromolecular Interactions in Cells (R01) Apply for RFA GM 13 003

Funding Number: RFA GM 13 003
Agency: National Institutes of Health
Category: Health
Funding Amount: $80,000
USAID/Uganda Therapeutic and Supplementary Products for Improved Nutrition (TASPIN) Apply for RFA 617 12 000002

Funding Number: RFA 617 12 000002
Agency: Uganda USAID Kampala
Category: Health
Funding Amount: $22,000,000
Rapid Response to Requests for Rural Data Analysis and Issue Specific Rural Research Studies Apply for HRSA 12 090

Funding Number: HRSA 12 090
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
Information Services to Rural Hospital Flexibility Grantees Program Cooperative Agreement (Technical Assistance Center) Apply for HRSA 12 098

Funding Number: HRSA 12 098
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
Leadership Group for a Clinical Research Network on Vaccines to Prevent HIV infection (UM1) Apply for RFA AI 12 012

Funding Number: RFA AI 12 012
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH12 1251", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.